Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Puma Biotechnology (PBYI) Tax Provisions (2020 - 2025)

Puma Biotechnology's Tax Provisions history spans 6 years, with the latest figure at -$1.0 million for Q4 2025.

  • For Q4 2025, Tax Provisions fell 40.34% year-over-year to -$1.0 million; the TTM value through Sep 2025 reached $288000.0, down 79.79%, while the annual FY2024 figure was $175000.0, 83.84% down from the prior year.
  • Tax Provisions reached -$1.0 million in Q4 2025 per PBYI's latest filing, down from $399000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $536000.0 in Q4 2023 to a low of -$1.0 million in Q4 2025.
  • Average Tax Provisions over 5 years is $79150.0, with a median of $167000.0 recorded in 2023.
  • Peak YoY movement for Tax Provisions: surged 432.92% in 2023, then plummeted 233.21% in 2024.
  • A 5-year view of Tax Provisions shows it stood at $212000.0 in 2021, then crashed by 175.94% to -$161000.0 in 2022, then soared by 432.92% to $536000.0 in 2023, then tumbled by 233.21% to -$714000.0 in 2024, then tumbled by 40.34% to -$1.0 million in 2025.
  • Per Business Quant, the three most recent readings for PBYI's Tax Provisions are -$1.0 million (Q4 2025), $399000.0 (Q3 2025), and $310000.0 (Q2 2025).